Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Spasojević, Ivan (58188331900)"

Filter results by typing the first few letters
Now showing 1 - 12 of 12
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    A comparative analysis of multiple sclerosis-relevant anti-inflammatory properties of ethyl pyruvate and dimethyl fumarate
    (2015)
    Miljković, Djordje (7006524033)
    ;
    Blazevski, Jana (53983581500)
    ;
    Petković, Filip (53985087100)
    ;
    Djedović, Neda (54902044600)
    ;
    Momcilović, Miljana (14050637900)
    ;
    Stanisavljević, Suzana (56545525300)
    ;
    Jevtić, Bojan (57191532541)
    ;
    Stojković, Marija Mostarica (6701741422)
    ;
    Spasojević, Ivan (58188331900)
    Dimethyl fumarate (DMF), a new drug for multiple sclerosis (MS) treatment, acts against neuroinflammation via mechanisms that are triggered by adduct formation with thiol redox switches. Ethyl pyruvate (EP), an off-the-shelf agent, appears to be a redox analog of DMF, but its immunomodulatory properties have not been put into the context of MS therapy. In this article, we examined and compared the effects of EP and DMF on MS-relevant activity/functions of T cells, macrophages, microglia, and astrocytes. EP efficiently suppressed the release of MS signature cytokines, IFN-γ and IL-17, from human PBMCs. Furthermore, the production of these cytokines was notably decreased in encephalitogenic T cells after in vivo application of EP to rats. Production of two other proinflammatory cytokines, IL-6 and TNF, and NO was suppressed by EP in macrophages and microglia. Reactive oxygen species production in macrophages, microglia activation, and the development of Ag-presenting phenotype in microglia and macrophages were constrained by EP. The release of IL-6 was reduced in astrocytes. Finally, EP inhibited the activation of transcription factor NF-κB in microglia and astrocytes. Most of these effects were also found for DMF, implying that EP and DMF share common targets and mechanisms of action. Importantly, EP had in vivo impact on experimental autoimmune encephalomyelitis, an animal model of MS. Treatment with EP resulted in delay and shortening of the first relapse, and lower clinical scores, whereas the second attack was annihilated. Further studies on the possibility to use EP as an MS therapeutic are warranted. Copyright © 2015 by The American Association of Immunologists, Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    A comparative analysis of multiple sclerosis-relevant anti-inflammatory properties of ethyl pyruvate and dimethyl fumarate
    (2015)
    Miljković, Djordje (7006524033)
    ;
    Blazevski, Jana (53983581500)
    ;
    Petković, Filip (53985087100)
    ;
    Djedović, Neda (54902044600)
    ;
    Momcilović, Miljana (14050637900)
    ;
    Stanisavljević, Suzana (56545525300)
    ;
    Jevtić, Bojan (57191532541)
    ;
    Stojković, Marija Mostarica (6701741422)
    ;
    Spasojević, Ivan (58188331900)
    Dimethyl fumarate (DMF), a new drug for multiple sclerosis (MS) treatment, acts against neuroinflammation via mechanisms that are triggered by adduct formation with thiol redox switches. Ethyl pyruvate (EP), an off-the-shelf agent, appears to be a redox analog of DMF, but its immunomodulatory properties have not been put into the context of MS therapy. In this article, we examined and compared the effects of EP and DMF on MS-relevant activity/functions of T cells, macrophages, microglia, and astrocytes. EP efficiently suppressed the release of MS signature cytokines, IFN-γ and IL-17, from human PBMCs. Furthermore, the production of these cytokines was notably decreased in encephalitogenic T cells after in vivo application of EP to rats. Production of two other proinflammatory cytokines, IL-6 and TNF, and NO was suppressed by EP in macrophages and microglia. Reactive oxygen species production in macrophages, microglia activation, and the development of Ag-presenting phenotype in microglia and macrophages were constrained by EP. The release of IL-6 was reduced in astrocytes. Finally, EP inhibited the activation of transcription factor NF-κB in microglia and astrocytes. Most of these effects were also found for DMF, implying that EP and DMF share common targets and mechanisms of action. Importantly, EP had in vivo impact on experimental autoimmune encephalomyelitis, an animal model of MS. Treatment with EP resulted in delay and shortening of the first relapse, and lower clinical scores, whereas the second attack was annihilated. Further studies on the possibility to use EP as an MS therapeutic are warranted. Copyright © 2015 by The American Association of Immunologists, Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Albumin at the intersection between antioxidant and pro-oxidant in patients on peritoneal dialysis
    (2022)
    Baralić, Marko (56258718700)
    ;
    Spasojević, Ivan (58188331900)
    ;
    Miljuš, Goran (36651540800)
    ;
    Šunderić, Miloš (55581497300)
    ;
    Robajac, Dragana (36651587600)
    ;
    Dobrijević, Zorana (55508308800)
    ;
    Gligorijević, Nikola (56088660000)
    ;
    Nedić, Olgica (7003642048)
    ;
    Penezić, Ana (57218439363)
    Albumin (HSA) is a multifunctional protein and due to its free Cys34 thiol group, represents a main source of free thiols in the circulation. This property of HSA, combined with its ability to sequester redox active Cu(II) ions, makes HSA a dominant circulatory antioxidant. End stage kidney disease (ESRD) is a condition accompanied by elevated oxidative stress. The aim of the present study was to examine changes in the antioxidative capacity of HSA and Cu(II) binding affinity in patients on peritoneal dialysis (PD), and relate it to the Cys34 thiol group content and other structural changes of this molecule. HSA molecules are modified in ESRD patients subjected to PD, having significantly lower thiol group and bound Cu(II) content, reduced antioxidant capacity, an increased content of advanced glycation end-products and altered conformation. Also, Cu(II) binding capacity of HSA in these patients is impaired, since a significant portion of the high-affinity metal-binding site is unable to interact with Cu(II). Taking into account that the concentration of Cu(II) in the circulation of ESRD patients is much higher than in healthy persons and that Cu(II) binding capacity of HSA in these patients is significantly impaired, HSA may be considered as a novel circulatory pro-oxidant, thus exacerbating oxidative stress. © 2022 Elsevier Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Albumin at the intersection between antioxidant and pro-oxidant in patients on peritoneal dialysis
    (2022)
    Baralić, Marko (56258718700)
    ;
    Spasojević, Ivan (58188331900)
    ;
    Miljuš, Goran (36651540800)
    ;
    Šunderić, Miloš (55581497300)
    ;
    Robajac, Dragana (36651587600)
    ;
    Dobrijević, Zorana (55508308800)
    ;
    Gligorijević, Nikola (56088660000)
    ;
    Nedić, Olgica (7003642048)
    ;
    Penezić, Ana (57218439363)
    Albumin (HSA) is a multifunctional protein and due to its free Cys34 thiol group, represents a main source of free thiols in the circulation. This property of HSA, combined with its ability to sequester redox active Cu(II) ions, makes HSA a dominant circulatory antioxidant. End stage kidney disease (ESRD) is a condition accompanied by elevated oxidative stress. The aim of the present study was to examine changes in the antioxidative capacity of HSA and Cu(II) binding affinity in patients on peritoneal dialysis (PD), and relate it to the Cys34 thiol group content and other structural changes of this molecule. HSA molecules are modified in ESRD patients subjected to PD, having significantly lower thiol group and bound Cu(II) content, reduced antioxidant capacity, an increased content of advanced glycation end-products and altered conformation. Also, Cu(II) binding capacity of HSA in these patients is impaired, since a significant portion of the high-affinity metal-binding site is unable to interact with Cu(II). Taking into account that the concentration of Cu(II) in the circulation of ESRD patients is much higher than in healthy persons and that Cu(II) binding capacity of HSA in these patients is significantly impaired, HSA may be considered as a novel circulatory pro-oxidant, thus exacerbating oxidative stress. © 2022 Elsevier Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Ante- and postpartum redox status of blood in women with inherited thrombophilia treated with heparin
    (2012)
    Pristov, Jelena Bogdanović (45661121500)
    ;
    Maglić, Dragana (55354723900)
    ;
    Opačić, Miloš (55354427800)
    ;
    Mandić, Vesna (23991079100)
    ;
    Miković, Željko (7801694296)
    ;
    Spasić, Mihajlo (7003503254)
    ;
    Spasojević, Ivan (58188331900)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Comparative analysis of antioxidative systems in malignant and benign brain tumours
    (2015)
    Bogosavljević, Vojislav (25224579800)
    ;
    Bajčetić, Milica (15727461400)
    ;
    Spasojević, Ivan (58188331900)
    Objectives: Comparison of redox conditions in malignant and benign tumours is essential for understanding the role of reactive oxygen species in the pathophysiology of aggressive cancer profiles. Here we compare antioxidative systems in highly malignant brain tumour - glioblastoma multiforme (GBM), and in meningioma, a benign brain tumour. Methods: Tumour tissues and blood of 67 GBM patients (mean age: 52.9 ±11.5 years) and 67 meningioma patients (59.2 ±10.2 years), and blood of 30 control subjects (50.8 ±12.8 years) were analysed via biochemical assays. Results: Components of glutathione system, which is responsible for H2O2 removal, showed lower activity/ level in GBM: glutathione peroxidase (GBM: 9.90 ± 0.22; meningioma: 11.78 ± 0.23 U/mg of proteins; P< 0.001), glutathione reductase (GBM: 3.83 ±0.13; meningioma: 4.67 ±0.11 U/mg of proteins; P< 0.001), and glutathione (GBM: 6.70 ±0.12; meningioma: 7.58 ± 0.14 umol/g of tissue; P< 0.001). In contrast, the rank order of glutathione reductase activity and glutathione level in erythrocytes was: GBM > meningioma > control. Superoxide dismutase and catalase activities were lower in the blood of cancer patients compared to controls. Discussion: Cells of malignant brain tumour show down-regulated antioxidative system which might result in increased levels of H2O2 compared to benign tumour tissue. © W. S. Maney & Son Ltd 2015.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Comparative analysis of antioxidative systems in malignant and benign brain tumours
    (2015)
    Bogosavljević, Vojislav (25224579800)
    ;
    Bajčetić, Milica (15727461400)
    ;
    Spasojević, Ivan (58188331900)
    Objectives: Comparison of redox conditions in malignant and benign tumours is essential for understanding the role of reactive oxygen species in the pathophysiology of aggressive cancer profiles. Here we compare antioxidative systems in highly malignant brain tumour - glioblastoma multiforme (GBM), and in meningioma, a benign brain tumour. Methods: Tumour tissues and blood of 67 GBM patients (mean age: 52.9 ±11.5 years) and 67 meningioma patients (59.2 ±10.2 years), and blood of 30 control subjects (50.8 ±12.8 years) were analysed via biochemical assays. Results: Components of glutathione system, which is responsible for H2O2 removal, showed lower activity/ level in GBM: glutathione peroxidase (GBM: 9.90 ± 0.22; meningioma: 11.78 ± 0.23 U/mg of proteins; P< 0.001), glutathione reductase (GBM: 3.83 ±0.13; meningioma: 4.67 ±0.11 U/mg of proteins; P< 0.001), and glutathione (GBM: 6.70 ±0.12; meningioma: 7.58 ± 0.14 umol/g of tissue; P< 0.001). In contrast, the rank order of glutathione reductase activity and glutathione level in erythrocytes was: GBM > meningioma > control. Superoxide dismutase and catalase activities were lower in the blood of cancer patients compared to controls. Discussion: Cells of malignant brain tumour show down-regulated antioxidative system which might result in increased levels of H2O2 compared to benign tumour tissue. © W. S. Maney & Son Ltd 2015.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Coordination and redox interactions of β-lactam antibiotics with Cu2+ in physiological settings and the impact on antibacterial activity
    (2018)
    Božić, Bojana (56689582200)
    ;
    Korać, Jelena (57204033451)
    ;
    Stanković, Dalibor M. (39362393700)
    ;
    Stanić, Marina (25931142000)
    ;
    Romanović, Mima (57193664646)
    ;
    Pristov, Jelena Bogdanović (45661121500)
    ;
    Spasić, Snežana (57210908554)
    ;
    Popović-Bijelić, Ana (21234276100)
    ;
    Spasojević, Ivan (58188331900)
    ;
    Bajčetić, Milica (15727461400)
    An increase in the copper pool in body fluids has been related to a number of pathological conditions, including infections. Copper ions may affect antibiotics via the formation of coordination bonds and/or redox reactions. Herein, we analyzed the interactions of Cu2+ with eight β-lactam antibiotics using UV–Vis spectrophotometry, EPR spectroscopy, and electrochemical methods. Penicillin G did not show any detectable interactions with Cu2+. Ampicillin, amoxicillin and cephalexin formed stable colored complexes with octahedral coordination environment of Cu2+ with tetragonal distortion, and primary amine group as the site of coordinate bond formation. These β-lactams increased the solubility of Cu2+ in the phosphate buffer. Ceftazidime and Cu2+ formed a complex with a similar geometry and gave rise to an organic radical. Ceftriaxone-Cu2+ complex appears to exhibit different geometry. All complexes showed 1:1 stoichiometry. Cefaclor reduced Cu2+ to Cu1+ that further reacted with molecular oxygen to produce hydrogen peroxide. Finally, meropenem underwent degradation in the presence of copper. The analysis of activity against Escherichia coli and Staphylococcus aureus showed that the effects of meropenem, amoxicillin, ampicillin, and ceftriaxone were significantly hindered in the presence of copper ions. The interactions with copper ions should be taken into account regarding the problem of antibiotic resistance and in the selection of the most efficient antimicrobial therapy for patients with altered copper homeostasis. © 2018 Elsevier Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Coordination and redox interactions of β-lactam antibiotics with Cu2+ in physiological settings and the impact on antibacterial activity
    (2018)
    Božić, Bojana (56689582200)
    ;
    Korać, Jelena (57204033451)
    ;
    Stanković, Dalibor M. (39362393700)
    ;
    Stanić, Marina (25931142000)
    ;
    Romanović, Mima (57217848349)
    ;
    Pristov, Jelena Bogdanović (45661121500)
    ;
    Spasić, Snežana (57210908554)
    ;
    Popović-Bijelić, Ana (21234276100)
    ;
    Spasojević, Ivan (58188331900)
    ;
    Bajčetić, Milica (15727461400)
    An increase in the copper pool in body fluids has been related to a number of pathological conditions, including infections. Copper ions may affect antibiotics via the formation of coordination bonds and/or redox reactions. Herein, we analyzed the interactions of Cu2+ with eight β-lactam antibiotics using UV–Vis spectrophotometry, EPR spectroscopy, and electrochemical methods. Penicillin G did not show any detectable interactions with Cu2+. Ampicillin, amoxicillin and cephalexin formed stable colored complexes with octahedral coordination environment of Cu2+ with tetragonal distortion, and primary amine group as the site of coordinate bond formation. These β-lactams increased the solubility of Cu2+ in the phosphate buffer. Ceftazidime and Cu2+ formed a complex with a similar geometry and gave rise to an organic radical. Ceftriaxone-Cu2+ complex appears to exhibit different geometry. All complexes showed 1:1 stoichiometry. Cefaclor reduced Cu2+ to Cu1+ that further reacted with molecular oxygen to produce hydrogen peroxide. Finally, meropenem underwent degradation in the presence of copper. The analysis of activity against Escherichia coli and Staphylococcus aureus showed that the effects of meropenem, amoxicillin, ampicillin, and ceftriaxone were significantly hindered in the presence of copper ions. The interactions with copper ions should be taken into account regarding the problem of antibiotic resistance and in the selection of the most efficient antimicrobial therapy for patients with altered copper homeostasis. © 2018 Elsevier Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Redox therapy in neonatal sepsis: reasons, targets, strategy, and agents
    (2014)
    Bajčetić, Milica (15727461400)
    ;
    Spasić, Snežana (57210908554)
    ;
    Spasojević, Ivan (58188331900)
    Neonatal sepsis is one of the most fulminating conditions in neonatal intensive care units. Antipathogen and supportive care are administered routinely, but do not deliver satisfactory results. In addition, the efforts to treat neonatal sepsis with anti-inflammatory agents have generally shown to be futile. The accumulating data imply that intracellular redox changes intertwined into neonatal sepsis redox cycle represent the main cause of dysfunction of mitochondria and cells in neonatal sepsis. Our aim here is to support the new philosophy in neonatal sepsis treatment, which involves the integration of mechanisms that are responsible for cellular dysfunction and organ failure, the recognition of the most important targets, and the selection of safe agents that can stop the neonatal sepsis redox cycle by hitting the hot spots. Redox-active agents that could be beneficial for neonatal sepsis treatment according to these criteria include lactoferrin, interleukin 10, zinc and selenium supplements, ibuprofen, edaravone, and pentoxifylline.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The effects of human wild-type and fals mutant L144P SOD1 on non-vascular smooth muscle contractions
    (2013)
    Nikolić-Kokić, Aleksandra (7005932022)
    ;
    Oreščanin-Dušić, Zorana (25226180800)
    ;
    Slavić, Marija (15754653400)
    ;
    Spasojević, Ivan (58188331900)
    ;
    Stević, Zorica (57204495472)
    ;
    Spasić, Mihajlo (7003503254)
    ;
    Blagojević, Duško (6603836388)
    Background: Mutated copper, zinc-containing superoxide dismutase (SOD1) may self-aggregate, an event that could also be an initial cause of motor neuron malfunction leading to disease onset. The effects of human mutated SOD1 pro- tein from the blood of familial amyotrophic lateral sclerosis (FALS) patients bearing Leu144Phe (L144F) mutation were compared to wild-type (WT) human SOD1 derived from healthy examinees, for enzymatic activity and the effects on isometric contractions of non-vascular smooth muscle. Methods: We isolated WT and L144F SOD1 enzymes from eight patients with FALS, L144F mutation in exon 5 and eight healthy controls. We then investigated SOD1 activities in the obtained samples by the adrenaline method and pro- filed them electrophoretically. Finally, we applied WT and L144F SOD1 on the isolated rat uterus. Results: L144F SOD1 showed lower superoxide-dismutating activity compared to WT human SOD1. We found that, in contrast to WT human SOD1, mutated L144F does not induce smooth muscle relaxation. Conclusions: Our data suggest that the lack of relaxation of muscle tonus in the presence of mutated SOD1 may have pathogenic feedback effects in FALS.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The effects of human wild-type and fals mutant L144P SOD1 on non-vascular smooth muscle contractions
    (2013)
    Nikolić-Kokić, Aleksandra (7005932022)
    ;
    Oreščanin-Dušić, Zorana (25226180800)
    ;
    Slavić, Marija (15754653400)
    ;
    Spasojević, Ivan (58188331900)
    ;
    Stević, Zorica (57204495472)
    ;
    Spasić, Mihajlo (7003503254)
    ;
    Blagojević, Duško (6603836388)
    Background: Mutated copper, zinc-containing superoxide dismutase (SOD1) may self-aggregate, an event that could also be an initial cause of motor neuron malfunction leading to disease onset. The effects of human mutated SOD1 pro- tein from the blood of familial amyotrophic lateral sclerosis (FALS) patients bearing Leu144Phe (L144F) mutation were compared to wild-type (WT) human SOD1 derived from healthy examinees, for enzymatic activity and the effects on isometric contractions of non-vascular smooth muscle. Methods: We isolated WT and L144F SOD1 enzymes from eight patients with FALS, L144F mutation in exon 5 and eight healthy controls. We then investigated SOD1 activities in the obtained samples by the adrenaline method and pro- filed them electrophoretically. Finally, we applied WT and L144F SOD1 on the isolated rat uterus. Results: L144F SOD1 showed lower superoxide-dismutating activity compared to WT human SOD1. We found that, in contrast to WT human SOD1, mutated L144F does not induce smooth muscle relaxation. Conclusions: Our data suggest that the lack of relaxation of muscle tonus in the presence of mutated SOD1 may have pathogenic feedback effects in FALS.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback